Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
37.40
+0.97 (2.66%)
Nov 19, 2024, 3:42 PM EST - Market open
Bright Minds Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 19, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Market Capitalization | 254 | 6 | 20 | 85 | - | - |
| Market Cap Growth | -60.50% | -70.74% | -75.79% | - | - | - |
| Enterprise Value | 250 | 0 | 14 | 67 | - | - |
| Last Close Price | 36.43 | 1.60 | 6.15 | 35.71 | - | - |
| PB Ratio | 1.01 | 1.23 | 2.67 | 5.51 | - | - |
| P/TBV Ratio | 1.01 | 1.23 | 2.67 | 5.51 | - | - |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | - | - | - |
| Quick Ratio | 34.75 | 24.16 | 8.00 | 31.12 | 5.30 | 2.18 |
| Current Ratio | 35.08 | 24.26 | 8.11 | 31.38 | 5.82 | 2.18 |
| Return on Equity (ROE) | -51.80% | -86.02% | -99.95% | -85.94% | -124.04% | - |
| Return on Assets (ROA) | -28.86% | -47.45% | -57.32% | -51.52% | -61.70% | - |
| Return on Capital (ROIC) | -30.53% | -51.86% | -61.21% | -53.54% | -76.64% | - |
| Earnings Yield | -1.03% | -90.90% | -53.20% | -8.09% | - | - |
| FCF Yield | -0.72% | -86.61% | -48.30% | -6.84% | - | - |
| Buyback Yield / Dilution | -19.17% | -50.57% | -37.64% | -148.42% | -74.24% | - |
| Total Shareholder Return | -19.17% | -50.57% | -37.64% | -148.42% | -74.24% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.